Medical Device News Magazine

Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma

Results presented at IMS 2026 show ZENBEXUS in combination with [...]

By |2026-09-25T14:22:13+00:00September 25, 2026|3rd Party Medical Device Industry News|Comments Off on Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma
Go to Top